Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jérémy T. Campillo"'
Autor:
Tristan M. Lepage, Jérémy T. Campillo, Frédéric Louya, Paul Bikita, François Missamou, Marlhand C. Hemilembolo, Sébastien D. S. Pion, Michel Boussinesq, Cédric B. Chesnais
Publikováno v:
Parasites & Vectors, Vol 17, Iss 1, Pp 1-15 (2024)
Abstract Background The standard method to diagnose Loa loa infection and quantify microfilarial density (MFD) is the microscopic examination of calibrated thick blood smears (TBSs). In 1950, it was noticed that successive L. loa MFD samples from a s
Externí odkaz:
https://doaj.org/article/2b2231c8d57f4fffb66b5e922e688b55
Autor:
Marlhand C. Hemilembolo, Jérémy T. Campillo, Ange Clauvel Niama, Sébastien D. S. Pion, François Missamou, Michel Boussinesq, Richard R. Bileckot, Cédric B. Chesnais
Publikováno v:
Parasites & Vectors, Vol 16, Iss 1, Pp 1-10 (2023)
Abstract Background Loiasis is endemic in the northern and western part of the Republic of Congo. Between 2004 and 2010, surveys were conducted, using the RAPLOA method, in all departments of the Republic of Congo to assess the distribution of loiasi
Externí odkaz:
https://doaj.org/article/ab460da045c1476797814c3aaf1710b9
Autor:
Jérémy T. Campillo, Marlhand C. Hemilembolo, Frédéric Louya, Paul Bikita, Sébastien D. S. Pion, Michel Boussinesq, François Missamou, Cédric B. Chesnais
Publikováno v:
Parasites & Vectors, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Background The diurnal periodicity of Loa loa microfilaraemia is well known but few studies have documented the short- and long-term stability of microfilarial density. It seems stable over time at the community level, but significant variat
Externí odkaz:
https://doaj.org/article/51a2642b2d0e4a6e93c11f5240b98e0a
Autor:
Jérémy T. Campillo, Frédéric Louya, Paul Bikita, François Missamou, Sébastien D. S. Pion, Michel Boussinesq, Cédric B. Chesnais
Publikováno v:
Parasites & Vectors, Vol 15, Iss 1, Pp 1-7 (2022)
Abstract Background Loa loa microfilariae circulate in the peripheral blood of human hosts following a diurnal periodicity, with maximal microfilaremia levels generally observed between 10:00 am and 3:00 pm. Few studies have assessed factors potentia
Externí odkaz:
https://doaj.org/article/4cf41096cc5e4fcc851b5ba8babbb9f1
Autor:
Jérémy T. Campillo, Naomi P. Awaca-Uvon, Jean-Paul Tambwe, Godefroy Kuyangisa-Simuna, Johnny Vlaminck, Gary J. Weil, Michel Boussinesq, Cédric B. Chesnais, Sébastien D. S. Pion
Publikováno v:
Parasites & Vectors, Vol 14, Iss 1, Pp 1-10 (2021)
Abstract Background The impact of semiannual mass drug administration (MDA) with albendazole (ALB; 400 mg) alone on lymphatic filariasis (LF) and soil-transmitted helminth (STH) infections was assessed during two trials conducted from 2012 to 2018 in
Externí odkaz:
https://doaj.org/article/512902568f1e4de490e2ba42bda327cd
Autor:
Jérémy T. Campillo, Cédric B. Chesnais, Sébastien D. S. Pion, Jacques Gardon, Joseph Kamgno, Michel Boussinesq
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background Little information is available on the effect of ivermectin on the third- and fourth-stage larvae of Onchocerca volvulus. To assess a possible prophylactic effect of ivermectin on this parasite, we compared the effects of differen
Externí odkaz:
https://doaj.org/article/b6559339342c4746b800ba1b58762fed
Autor:
Marlhand C Hemilembolo, Ange Clauvel Niama, Jérémy T Campillo, Sébastien D Pion, François Missamou, Charles Whittaker, Jean-Médard Kankou, Gilbert Ndziessi, Richard R Bileckot, Michel Boussinesq, Cédric B Chesnais
Publikováno v:
Open Forum Infectious Diseases. 10
BackgroundLoiasis (Loa loa filariasis) is considered a benign disease and is currently not included in the World Health Organization’s (WHO's) list of Neglected Tropical Diseases, despite mounting evidence suggesting significant disease burden in e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c9f30fd66b804a4c48347e1df66d68
https://doi.org/10.1093/ofid/ofad103
https://doi.org/10.1093/ofid/ofad103
Autor:
Guy Sadeu Wafeu, Tristan M. Lepage, Jérémy T. Campillo, Arnauld Efon-Ekangouo, Hugues Nana Djeunga, Narcisse Nzune-Toche, André Domche, Laurentine Sumo, Guy-Roger Njitchouang, Martine Augusta Flore Tsasse, Jean Bopda, Yves Aubin Balog, Yannick Niamsi-Emalio, Stève Mbickmen-Tchana, Gervais Kamga Talla, Yannick Sédrick Nguedia Kana, Félicité Diane Maga Messina, Sébastien D. Pion, Annette C. Kuesel, Joseph Kamgno, Michel Boussinesq, Cédric B. Chesnais
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4611db8ea36e7547fc6eef861666193f
https://doi.org/10.2139/ssrn.4439152
https://doi.org/10.2139/ssrn.4439152
Autor:
Jérémy T. Campillo, Marlhand C. Hemilembolo, Frederic Louya, Paul Bikita, Sebastien D. S. Pion, Michel Boussinesq, Francois Missamou, Cédric B. Chesnais
Background The diurnal periodicity of Loa loa microfilaremia is well known but few studies have documented the short-term and long-term stability of microfilarial density. It seems stable over time at the community level, but significant variations h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bd19fd1f7474d86eaacff96dbe6fbae
https://doi.org/10.21203/rs.3.rs-2045683/v1
https://doi.org/10.21203/rs.3.rs-2045683/v1
Autor:
Jérémy T, Campillo, Céline, Eiden, Michel, Boussinesq, Sébastien D S, Pion, Jean-Luc, Faillie, Cédric B, Chesnais
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2022, 88 (3), pp.1094-1106. ⟨10.1111/bcp.15037⟩
British Journal of Clinical Pharmacology, 2022, 88 (3), pp.1094-1106. ⟨10.1111/bcp.15037⟩
Levamisole was initially prescribed for the treatment of intestinal worms. Because of immunomodulatory properties, levamisole has been used in inflammatory pathologies and in cancers in association with 5-fluorouracil. Levamisole is misused as a coca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1f393aa34b3e3d493f37f4f32887a067
https://hal.science/hal-03853323/file/BCP-88-1094(1).pdf
https://hal.science/hal-03853323/file/BCP-88-1094(1).pdf